Codexis Raises $37 Million in Series D Private Financing; Total to Be Raised Up to $40 Million
Codexis, Inc., a privately held biotechnology company, today announced it has raised $37 million in a Series D financing. 
Next Story: For ‘cleantech’ capitalists, the green that matters is on dollar bills
Previous Story: ChemoCentryx Completes Series C Financing
